Cargando…

Guidelines for multi-model comparisons of the impact of infectious disease interventions

BACKGROUND: Despite the increasing popularity of multi-model comparison studies and their ability to inform policy recommendations, clear guidance on how to conduct multi-model comparisons is not available. Herein, we present guidelines to provide a structured approach to comparisons of multiple mod...

Descripción completa

Detalles Bibliográficos
Autores principales: den Boon, Saskia, Jit, Mark, Brisson, Marc, Medley, Graham, Beutels, Philippe, White, Richard, Flasche, Stefan, Hollingsworth, T. Déirdre, Garske, Tini, Pitzer, Virginia E., Hoogendoorn, Martine, Geffen, Oliver, Clark, Andrew, Kim, Jane, Hutubessy, Raymond
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6699075/
https://www.ncbi.nlm.nih.gov/pubmed/31422772
http://dx.doi.org/10.1186/s12916-019-1403-9
_version_ 1783444657185751040
author den Boon, Saskia
Jit, Mark
Brisson, Marc
Medley, Graham
Beutels, Philippe
White, Richard
Flasche, Stefan
Hollingsworth, T. Déirdre
Garske, Tini
Pitzer, Virginia E.
Hoogendoorn, Martine
Geffen, Oliver
Clark, Andrew
Kim, Jane
Hutubessy, Raymond
author_facet den Boon, Saskia
Jit, Mark
Brisson, Marc
Medley, Graham
Beutels, Philippe
White, Richard
Flasche, Stefan
Hollingsworth, T. Déirdre
Garske, Tini
Pitzer, Virginia E.
Hoogendoorn, Martine
Geffen, Oliver
Clark, Andrew
Kim, Jane
Hutubessy, Raymond
author_sort den Boon, Saskia
collection PubMed
description BACKGROUND: Despite the increasing popularity of multi-model comparison studies and their ability to inform policy recommendations, clear guidance on how to conduct multi-model comparisons is not available. Herein, we present guidelines to provide a structured approach to comparisons of multiple models of interventions against infectious diseases. The primary target audience for these guidelines are researchers carrying out model comparison studies and policy-makers using model comparison studies to inform policy decisions. METHODS: The consensus process used for the development of the guidelines included a systematic review of existing model comparison studies on effectiveness and cost-effectiveness of vaccination, a 2-day meeting and guideline development workshop during which mathematical modellers from different disease areas critically discussed and debated the guideline content and wording, and several rounds of comments on sequential versions of the guidelines by all authors. RESULTS: The guidelines provide principles for multi-model comparisons, with specific practice statements on what modellers should do for six domains. The guidelines provide explanation and elaboration of the principles and practice statements as well as some examples to illustrate these. The principles are (1) the policy and research question – the model comparison should address a relevant, clearly defined policy question; (2) model identification and selection – the identification and selection of models for inclusion in the model comparison should be transparent and minimise selection bias; (3) harmonisation – standardisation of input data and outputs should be determined by the research question and value of the effort needed for this step; (4) exploring variability – between- and within-model variability and uncertainty should be explored; (5) presenting and pooling results – results should be presented in an appropriate way to support decision-making; and (6) interpretation – results should be interpreted to inform the policy question. CONCLUSION: These guidelines should help researchers plan, conduct and report model comparisons of infectious diseases and related interventions in a systematic and structured manner for the purpose of supporting health policy decisions. Adherence to these guidelines will contribute to greater consistency and objectivity in the approach and methods used in multi-model comparisons, and as such improve the quality of modelled evidence for policy. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12916-019-1403-9) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6699075
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-66990752019-08-26 Guidelines for multi-model comparisons of the impact of infectious disease interventions den Boon, Saskia Jit, Mark Brisson, Marc Medley, Graham Beutels, Philippe White, Richard Flasche, Stefan Hollingsworth, T. Déirdre Garske, Tini Pitzer, Virginia E. Hoogendoorn, Martine Geffen, Oliver Clark, Andrew Kim, Jane Hutubessy, Raymond BMC Med Guideline BACKGROUND: Despite the increasing popularity of multi-model comparison studies and their ability to inform policy recommendations, clear guidance on how to conduct multi-model comparisons is not available. Herein, we present guidelines to provide a structured approach to comparisons of multiple models of interventions against infectious diseases. The primary target audience for these guidelines are researchers carrying out model comparison studies and policy-makers using model comparison studies to inform policy decisions. METHODS: The consensus process used for the development of the guidelines included a systematic review of existing model comparison studies on effectiveness and cost-effectiveness of vaccination, a 2-day meeting and guideline development workshop during which mathematical modellers from different disease areas critically discussed and debated the guideline content and wording, and several rounds of comments on sequential versions of the guidelines by all authors. RESULTS: The guidelines provide principles for multi-model comparisons, with specific practice statements on what modellers should do for six domains. The guidelines provide explanation and elaboration of the principles and practice statements as well as some examples to illustrate these. The principles are (1) the policy and research question – the model comparison should address a relevant, clearly defined policy question; (2) model identification and selection – the identification and selection of models for inclusion in the model comparison should be transparent and minimise selection bias; (3) harmonisation – standardisation of input data and outputs should be determined by the research question and value of the effort needed for this step; (4) exploring variability – between- and within-model variability and uncertainty should be explored; (5) presenting and pooling results – results should be presented in an appropriate way to support decision-making; and (6) interpretation – results should be interpreted to inform the policy question. CONCLUSION: These guidelines should help researchers plan, conduct and report model comparisons of infectious diseases and related interventions in a systematic and structured manner for the purpose of supporting health policy decisions. Adherence to these guidelines will contribute to greater consistency and objectivity in the approach and methods used in multi-model comparisons, and as such improve the quality of modelled evidence for policy. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12916-019-1403-9) contains supplementary material, which is available to authorized users. BioMed Central 2019-08-19 /pmc/articles/PMC6699075/ /pubmed/31422772 http://dx.doi.org/10.1186/s12916-019-1403-9 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Guideline
den Boon, Saskia
Jit, Mark
Brisson, Marc
Medley, Graham
Beutels, Philippe
White, Richard
Flasche, Stefan
Hollingsworth, T. Déirdre
Garske, Tini
Pitzer, Virginia E.
Hoogendoorn, Martine
Geffen, Oliver
Clark, Andrew
Kim, Jane
Hutubessy, Raymond
Guidelines for multi-model comparisons of the impact of infectious disease interventions
title Guidelines for multi-model comparisons of the impact of infectious disease interventions
title_full Guidelines for multi-model comparisons of the impact of infectious disease interventions
title_fullStr Guidelines for multi-model comparisons of the impact of infectious disease interventions
title_full_unstemmed Guidelines for multi-model comparisons of the impact of infectious disease interventions
title_short Guidelines for multi-model comparisons of the impact of infectious disease interventions
title_sort guidelines for multi-model comparisons of the impact of infectious disease interventions
topic Guideline
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6699075/
https://www.ncbi.nlm.nih.gov/pubmed/31422772
http://dx.doi.org/10.1186/s12916-019-1403-9
work_keys_str_mv AT denboonsaskia guidelinesformultimodelcomparisonsoftheimpactofinfectiousdiseaseinterventions
AT jitmark guidelinesformultimodelcomparisonsoftheimpactofinfectiousdiseaseinterventions
AT brissonmarc guidelinesformultimodelcomparisonsoftheimpactofinfectiousdiseaseinterventions
AT medleygraham guidelinesformultimodelcomparisonsoftheimpactofinfectiousdiseaseinterventions
AT beutelsphilippe guidelinesformultimodelcomparisonsoftheimpactofinfectiousdiseaseinterventions
AT whiterichard guidelinesformultimodelcomparisonsoftheimpactofinfectiousdiseaseinterventions
AT flaschestefan guidelinesformultimodelcomparisonsoftheimpactofinfectiousdiseaseinterventions
AT hollingsworthtdeirdre guidelinesformultimodelcomparisonsoftheimpactofinfectiousdiseaseinterventions
AT garsketini guidelinesformultimodelcomparisonsoftheimpactofinfectiousdiseaseinterventions
AT pitzervirginiae guidelinesformultimodelcomparisonsoftheimpactofinfectiousdiseaseinterventions
AT hoogendoornmartine guidelinesformultimodelcomparisonsoftheimpactofinfectiousdiseaseinterventions
AT geffenoliver guidelinesformultimodelcomparisonsoftheimpactofinfectiousdiseaseinterventions
AT clarkandrew guidelinesformultimodelcomparisonsoftheimpactofinfectiousdiseaseinterventions
AT kimjane guidelinesformultimodelcomparisonsoftheimpactofinfectiousdiseaseinterventions
AT hutubessyraymond guidelinesformultimodelcomparisonsoftheimpactofinfectiousdiseaseinterventions